Dr. Mark Lee, M.D., Ph.D., N-Power Medicine

N-Power Medicine Raises $72M in Series B Funding to Advance Oncology Clinical Trials Platform

N-Power Medicine, a trailblazer in redefining the clinical trial landscape, has announced a significant milestone with the closure of its Series B funding round, securing $72 million in total funding. Led by the Merck Global Health Innovation Fund, alongside a prominent U.S.-based healthcare investor, this funding infusion marks a pivotal moment for N-Power Medicine as…

Read More

Unrivaled Excellence: Cognigy Secures Consecutive Win in AI Breakthrough Awards 2024

Cognigy, a pioneer in AI-driven customer service solutions, proudly announces its consecutive victory in the prestigious AI Breakthrough Awards 2024, clinching the title of “Best Natural Language Understanding Solution” for the second year running. Hosted by AI Breakthrough, a leading market intelligence firm, the annual awards program recognizes outstanding achievements in artificial intelligence across various…

Read More

Instructure Bolsters K-12 Credentialing with Scribbles Acquisition

Instructure Holdings, Inc. (NYSE: INST), a leading provider of learning management solutions, announced today the successful completion of its acquisition of Scribbles, a prominent K-12 credentialing and records management company based in Charlotte, North Carolina. This strategic move strengthens Instructure’s foothold in the K-12 space by expanding its credentialing network and bolstering its support for…

Read More

Anbogen Therapeutics Secures $7.3M to Propel ABT-301 Cancer Therapy to Phase II Trials

Anbogen Therapeutics, a leading name in cancer therapeutics development, has announced the successful completion of an oversubscribed A+ round financing, securing USD 7.3 million to advance their groundbreaking cancer treatment, ABT-301. This latest funding round follows on the heels of a USD 12.5 million Series A round earlier this year, bringing Anbogen’s total funding to…

Read More

Kanvas Biosciences Secures $12.5M to Propel Microbiome-Based Cancer Therapies

Kanvas Biosciences, a pioneering spatial biology company, has announced a significant stride in its mission to revolutionize healthcare with microbiome-based therapies. With an additional $12.5 million in funding co-led by DCVC and Lions Capital LLC, and supported by FemHealth Ventures, Germin8, Ki Tua Fund, and Pangaea Ventures, alongside existing investors, the company’s total funding now…

Read More

ISPTech Secures €2 Million to Propel Green Spacetech Innovation

InSpacePropulsion Technologies (ISPTech), a pioneering spin-off from the German Aerospace Center (DLR), has announced a significant milestone with a €2 million Pre-Seed funding round. This investment underscores ISPTech’s commitment to revolutionizing the space industry with its innovative green propulsion systems, designed to enhance performance, reliability, and affordability across a wide range of spacecraft applications. Founded…

Read More

Grosvenor UK Ventures into Proptech Future with Strategic Investment in noa

In a strategic move signaling its commitment to innovation in the real estate sector, Grosvenor’s UK property business has announced its inaugural investment in noa, Europe’s largest proptech venture capital firm. Founded in 2019 and formerly known as A/O, noa is at the forefront of leveraging technology to revolutionize the built world industry, aiming to…

Read More

Cluby Secures €2.9 Million to Revolutionize Restaurant Connectivity Across Europe

In a bid to transform the way restaurants engage with their patrons, Finnish startup Cluby has announced a significant milestone in its journey: securing €2.9 million in Seed funding. This investment, led by Vendep Capital with participation from industry luminaries including Pekka Koskinen and Elias Aalto, marks a pivotal moment for Cluby as it accelerates…

Read More

Seaya Andromeda Secures €300 Million for Southern Europe’s First Article 9 Climatetech Fund

In a landmark achievement for Spain’s venture capital landscape, Seaya, a prominent investment firm based in Madrid, has successfully closed its Seaya Andromeda fund at an impressive €300 million. This fund marks Southern Europe’s pioneering Article 9 climatetech initiative, dedicated to advancing impact-driven growth in sectors crucial to global sustainability. Seaya Andromeda focuses its investments…

Read More

Vytal Secures €6.2 Million to Expand Reusable Packaging Technology

Vytal, a trailblazer in software-enabled reusable packaging solutions, has successfully closed a €6.2 million growth financing round aimed at advancing its mission in promoting sustainability within the packaging industry. The funding was led by Emerald Technology through its Sustainable Packaging Innovation Fund, with participation from Ventis, Kiko Ventures, Grazia Equity, and Rubio, underscoring strong support…

Read More